Merck (MRK) Director Karsanbhai Lanca Receives 111.83-Share Award

What Happened Karsanbhai Surendralal Lanca, a director of Merck & Co., received a grant of 111.83 shares classified as a derivative award on 2026-09-30. The filing lists an acquisition price of $145.31 per unit, giving a total reported value of $16,250. This was an award/grant (code A) — part of director compensation — not an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-30; Filing date (accession): 2026-10-01 (filed one day after the transaction).
• Award: 111.83 units at $145.31 each; total reported value $16,250.
• Transaction type: Grant/award of a derivative (phantom stock units), not a stock purchase or sale.
• Settlement: Footnote F2 states these phantom stock units are to be settled 100% in cash upon the reporting person’s termination of service, per the Plan for Deferred Payment of Directors' Compensation.
• Other footnotes: F1 indicates a 1-for-1 ratio; F3 notes holdings may include shares from dividend reinvestment transactions.
• Shares owned after the transaction: Not specified in the provided filing excerpt.

Context This is routine director compensation (phantom stock units) rather than an outright equity purchase or sale. Because the units are payable in cash upon termination under the plan, they do not immediately increase the insider’s voting share count. The filing appears timely (filed the next day); no late filing indication was provided.